標(biāo)題: Titlebook: Nucleic Acid Therapeutics in Cancer; Alan M. Gewirtz Book 2004 Springer Science+Business Media New York 2004 DNA.cancer.tumor.tumor growth [打印本頁(yè)] 作者: Neogamist 時(shí)間: 2025-3-21 17:17
書目名稱Nucleic Acid Therapeutics in Cancer影響因子(影響力)
書目名稱Nucleic Acid Therapeutics in Cancer影響因子(影響力)學(xué)科排名
書目名稱Nucleic Acid Therapeutics in Cancer網(wǎng)絡(luò)公開(kāi)度
書目名稱Nucleic Acid Therapeutics in Cancer網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書目名稱Nucleic Acid Therapeutics in Cancer被引頻次
書目名稱Nucleic Acid Therapeutics in Cancer被引頻次學(xué)科排名
書目名稱Nucleic Acid Therapeutics in Cancer年度引用
書目名稱Nucleic Acid Therapeutics in Cancer年度引用學(xué)科排名
書目名稱Nucleic Acid Therapeutics in Cancer讀者反饋
書目名稱Nucleic Acid Therapeutics in Cancer讀者反饋學(xué)科排名
作者: 斑駁 時(shí)間: 2025-3-21 21:40
978-1-4684-9858-5Springer Science+Business Media New York 2004作者: CANT 時(shí)間: 2025-3-22 01:04
Nucleic Acid Therapeutics in Cancer978-1-59259-777-2Series ISSN 2196-9906 Series E-ISSN 2196-9914 作者: jet-lag 時(shí)間: 2025-3-22 07:54 作者: 幸福愉悅感 時(shí)間: 2025-3-22 11:41
https://doi.org/10.1007/978-1-59259-777-2DNA; cancer; tumor; tumor growth作者: 修飾 時(shí)間: 2025-3-22 13:09
David A. Dunbar PhD,Susan J. Baserga MD, PhDon its epistemic roots where modernity (understood as a Western enlightenment model) is taken as a baseline. The chapter makes a case for more radical alternative futures for transitional justice, enshrined in the tenants of decolonial theory.作者: babble 時(shí)間: 2025-3-22 18:30 作者: gruelling 時(shí)間: 2025-3-22 23:10 作者: cochlea 時(shí)間: 2025-3-23 02:21 作者: 中世紀(jì) 時(shí)間: 2025-3-23 07:35 作者: BIDE 時(shí)間: 2025-3-23 13:46
Mechanism of Action of Antisense RNA in Eukaryotic Cellsal years that the formation of double-stranded RNA (dsRNA), triggers a variety of cellular effects that depend not only on the length of the RNA duplex, but also on its intracellular location and on the cell type .. These effects include activation of the protein kinase (PKR) and RNase L pathways, i作者: 伙伴 時(shí)間: 2025-3-23 16:17
Considerations on the Design of Antisense OligonucleotidessON. This annealing step seems to be strongly influenced by the complex target structure and by characteristics of the asON sequence itself. It is desirable to understand those characteristics because the selection of favorable local target motifs along along-chain target RNA crucially determines ef作者: 考博 時(shí)間: 2025-3-23 21:36 作者: 遺棄 時(shí)間: 2025-3-24 00:31 作者: pulmonary 時(shí)間: 2025-3-24 02:51
Eric Vivès PhD,Jean Philippe Richard MSc,Bernard Lebleu PhDvol 539 1983: vol 1117 1993: vol 1608 2000: vol 1816 1976: vol 598 1984: vol 1180 1994: vol 1648 2001: vol 1837 & 1851 1977: vol 678 1985/86/87: vol 1362 & S-50 2002: vol 1840 1978: vol 774 198978-3-540-30988-8978-3-540-34806-1Series ISSN 0075-8434 Series E-ISSN 1617-9692 作者: Semblance 時(shí)間: 2025-3-24 10:17 作者: Charade 時(shí)間: 2025-3-24 11:53 作者: GRILL 時(shí)間: 2025-3-24 16:47
Lida K. Gifford PhD,Ponzy Lu PhD,Alan M. Gewirtz MDvol 539 1983: vol 1117 1993: vol 1608 2000: vol 1816 1976: vol 598 1984: vol 1180 1994: vol 1648 2001: vol 1837 & 1851 1977: vol 678 1985/86/87: vol 1362 & S-50 2002: vol 1840 1978: vol 774 198978-3-540-30988-8978-3-540-34806-1Series ISSN 0075-8434 Series E-ISSN 1617-9692 作者: 彎曲道理 時(shí)間: 2025-3-24 21:42
Joanna B. Opalinska MD,Susan E. Shetzline PhDvol 539 1983: vol 1117 1993: vol 1608 2000: vol 1816 1976: vol 598 1984: vol 1180 1994: vol 1648 2001: vol 1837 & 1851 1977: vol 678 1985/86/87: vol 1362 & S-50 2002: vol 1840 1978: vol 774 198978-3-540-30988-8978-3-540-34806-1Series ISSN 0075-8434 Series E-ISSN 1617-9692 作者: GNAW 時(shí)間: 2025-3-25 00:41
Rosel Kretschmer-Kazemi Far PhD,Jens M. Warnecke PhD,Georg Sczakiel PhD81: vol 976 1991: vol 1541 1998: vol 1738 1974: vol 480 1982: vol 1097 1992: vol 1581 1999: vol 1781 1975: vol 539 1983: vol 1117 1993: vol 1608 2000: vol 1816 1976: vol 598 1984: vol 1180 1994: vol 1648 2001: vol 1837 & 1851 1977: vol 678 1985/86/87: vol 1362 & S-50 2002: vol 1840 1978: vol 774 198作者: 桉樹(shù) 時(shí)間: 2025-3-25 05:25 作者: Palter 時(shí)間: 2025-3-25 09:28 作者: Inelasticity 時(shí)間: 2025-3-25 13:39 作者: 不適 時(shí)間: 2025-3-25 17:43 作者: 大溝 時(shí)間: 2025-3-25 22:52 作者: 人工制品 時(shí)間: 2025-3-26 00:33
R. L. Juliano PhD by the Professors Cerf, Lyons and Slade. We have decided to publish these courses separately. This volume contains the course of Professor Cerf. We cordially thank the author for his performance at the summer school, and for the redaction of these notes. 69 participants have attended this school. 3作者: 清醒 時(shí)間: 2025-3-26 05:27 作者: 萬(wàn)神殿 時(shí)間: 2025-3-26 08:42
Guy Zuber PhD,Jean-Serge Remy PhD,Patrick Erbacher PhD,Pascale Belguise PhD,Jean-Paul Behr PhD by the Professors Cerf, Lyons and Slade. We have decided to publish these courses separately. This volume contains the course of Professor Cerf. We cordially thank the author for his performance at the summer school, and for the redaction of these notes. 69 participants have attended this school. 3作者: 休戰(zhàn) 時(shí)間: 2025-3-26 14:16
by the Professors Cerf, Lyons and Slade. We have decided to publish these courses separately. This volume contains the course of Professor Cerf. We cordially thank the author for his performance at the summer school, and for the redaction of these notes. 69 participants have attended this school. 3作者: gangrene 時(shí)間: 2025-3-26 17:05
Rosel Kretschmer-Kazemi Far PhD,Jens M. Warnecke PhD,Georg Sczakiel PhDe have decided to publish these courses separately. This volume contains the course of Professor Cerf. We cordially thank the author for his performance at the summer school, and for the redaction of these notes. 69 participants have attended this school. 35 of them have given a short lecture. The l作者: 有角 時(shí)間: 2025-3-26 21:08
Lida K. Gifford PhD,Ponzy Lu PhD,Alan M. Gewirtz MD by the Professors Cerf, Lyons and Slade. We have decided to publish these courses separately. This volume contains the course of Professor Cerf. We cordially thank the author for his performance at the summer school, and for the redaction of these notes. 69 participants have attended this school. 3作者: 元音 時(shí)間: 2025-3-27 02:10 作者: Free-Radical 時(shí)間: 2025-3-27 06:41 作者: Consensus 時(shí)間: 2025-3-27 11:07 作者: 頂點(diǎn) 時(shí)間: 2025-3-27 16:16
Antisense Methodology) complementary to a region of an mRNA to form a complex should prevent the ribosome from traveling along the message and thus prevent translation . . Now, with 25 years of experience, we realize that we have overlooked a fair number of problems associated with this strategy. However, this time has 作者: Alienated 時(shí)間: 2025-3-27 20:47 作者: ventilate 時(shí)間: 2025-3-27 23:38
Targeted Genome Modification Via Triple Helix Formationr progression of different diseases. This research has led to new and innovative therapies in the treatment of disease. Traditionally, most active drugs are inhibitors of proteins. However, in recent years synthetic oligonucleotides have been developed as a means to rationally design therapeutic age作者: RECUR 時(shí)間: 2025-3-28 02:58
Therapeutic Applications of Ribozymesr forming covalent bonds with extraordinary specificity, accelerating the rate of these reactions. The ability of RNA to serve as a catalyst was first shown for the self-splicing Group I intron of . and the RNA moiety of RNase P .. Subsequent to the discovery of these two RNA enzymes, RNA-mediated c作者: verdict 時(shí)間: 2025-3-28 06:56 作者: 顯示 時(shí)間: 2025-3-28 12:39
Targeted Destruction of Small, Stable RNAsnucleotides (ONs) were originally used to destroy mRNAs in order to reveal the function of specific proteins, their use has logically been extended to therapy for diseases that result from the unwanted expression of specific proteins, as in cancer. However, choosing the ON to target mRNAs in these c作者: Antagonist 時(shí)間: 2025-3-28 17:41
Mechanism of Action of Antisense RNA in Eukaryotic Cellstranscripts that have the potential to form duplex RNA hybrids with their target messages .. Although there are numerous examples in the literature of the successful application of antisense strategy, the many failures and frustrations have been less well documented. Recent work from a number of lab作者: Immortal 時(shí)間: 2025-3-28 19:16 作者: PLAYS 時(shí)間: 2025-3-29 01:23 作者: overhaul 時(shí)間: 2025-3-29 04:38 作者: 尊嚴(yán) 時(shí)間: 2025-3-29 11:12 作者: overweight 時(shí)間: 2025-3-29 12:17
Identification of Hybridization Accessible Sequence in Messenger RNAAs are inhibited .. We have hypothesized that the inability to predict mRNA structure in vivo is a significant component of this problem because it is not known which regions of an mRNA molecule are accessible for basepairing or other recognition processes. A number of strategies have been developed作者: 粗糙濫制 時(shí)間: 2025-3-29 16:38
Nucleic Acids As Gene-Targeting Therapeuticspossibility exists that manipulation of expression of the causative gene, or genes, could have significant therapeutic consequences. Furthermore, because biological processes are virtually always the result of the balance between stimulatory and inhibitory effects, it is difficult to imagine a situa作者: 教育學(xué) 時(shí)間: 2025-3-29 19:47 作者: TRAWL 時(shí)間: 2025-3-30 02:14
Book 2004ogy and delivery to targeting and clinical targets. The authors thoroughly explain the latest developments in RNA biology, as well as the underpinnings of RNA interference, oligodeoxynucleotide delivery into cells, and strategies for targeting these molecules to accessible regions within the mRNA. T作者: 籠子 時(shí)間: 2025-3-30 07:48 作者: 為敵 時(shí)間: 2025-3-30 08:41
2196-9906 es to accessible regions within the mRNA. They also provide some examples of how these new therapeutic compounds are being used clinically.978-1-4684-9858-5978-1-59259-777-2Series ISSN 2196-9906 Series E-ISSN 2196-9914 作者: Vaginismus 時(shí)間: 2025-3-30 14:04
Molecular Vectors for Gene Delivery to Cancer Cells immune system. Although the latter consequence can be turned into therapeutic benefit, the former excludes repetitive treatment, which is the only reasonable approach for a chronic disease such as cancer.作者: Anticlimax 時(shí)間: 2025-3-30 20:10
Identification of Hybridization Accessible Sequence in Messenger RNA not known which regions of an mRNA molecule are accessible for basepairing or other recognition processes. A number of strategies have been developed to ask if a region of mRNA is single-stranded and free of bound protein, but all have their limitations. Accordingly, we have attempted to develop a different approach to this problem.作者: 責(zé)怪 時(shí)間: 2025-3-30 21:03 作者: plasma-cells 時(shí)間: 2025-3-31 01:52 作者: 鎮(zhèn)痛劑 時(shí)間: 2025-3-31 08:56
2196-9906 silencing. Topics range from basic methodology and delivery to targeting and clinical targets. The authors thoroughly explain the latest developments in RNA biology, as well as the underpinnings of RNA interference, oligodeoxynucleotide delivery into cells, and strategies for targeting these molecul
